Horst Knapp, DPM
Podiatrist · Frisco, TXNPI 1922059724
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.1%), education and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 29.9% of the total.
Across 219 payments — averaging $69.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$5K
- Arthrex$3K
- Pylant Medical$3K
- Stryker$2K
- Nevro Corp.$496
- Amgen$411
- plus $2K from 28 others
What the payments were for
- Travel & lodging$1,84512%
- Food & beverage$8,32255%
- Education$4,94933%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 52 | $4,521 |
| Arthrex | 16 | $3,214 |
| Pylant Medical | 15 | $2,927 |
| Stryker(2 entities) | 28 | $1,594 |
| Nevro Corp. | 10 | $496 |
| Amgen | 11 | $411 |
| Smith+Nephew | 15 | $308 |
| Pacira Pharmaceuticals Incorporated | 5 | $297 |
| Johnson & Johnson | 5 | $169 |
| Orthofix Medical, Inc. | 18 | $166 |
| Osteoremedies, LLC | 1 | $153 |
| Paratek Pharmaceuticals, Inc. | 7 | $135 |
| Anika Therapeutics, Inc. | 1 | $117 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $101 |
| IBSA Pharma Inc. | 5 | $78 |
| Melinta Therapeutics, LLC | 3 | $61 |
| Biotissue Holdings Inc. | 2 | $33 |
| Convatec Inc. | 1 | $31 |
| Averitas Pharma Inc. | 1 | $30 |
| Glenmark Therapeutics Inc. | 2 | $29 |
| Zimmer Biomet | 1 | $26 |
| Bsn Medical Inc | 2 | $25 |
| Nabriva Therapeutics, PLC | 2 | $25 |
| Vertex | 1 | $22 |
| Medline Industries LP | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Integra Lifesciences Corporation | 1 | $17 |
| Nvision Biomedical Technologies, Inc. | 1 | $16 |
| Sebela Pharmaceuticals Inc. | 1 | $15 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Abbott | 1 | $13 |
| Tactile Systems Technology Inc | 1 | $12 |
| Amniox Medical, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$2,625
- PERCUPLASTY TRAY$473
- Omnia$357
- TMC NANOPLASTY SYSTEM$300
- AUGMENT INJECTABLE$254
- KRYSTEXXA$250
- TMC PSI CUT GUIDE SYSTEM$212
- INFINITY$166
- BlastX$153
- Xperience$153
- SALVATION$141
- PROPHECY$138
- VALOR$138
- INBONE$137
- EXPAREL$125
- TACTOSET$117
- CLAW II$106
How this compares
$15,116 in reported general payments places this provider in the 85th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 15 | $11,385 |
| Econazole Nitrate | 27 | $726 |
| Cephalexin | 11 | $363 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 36 | $290 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $188 |
| Ondansetron OdtOndansetron | 13 | $147 |
| Gabapentin | 24 | $143 |
| CiclopiroxCiclopirox Olamine | 13 | $103 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $30 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $101 | $11,38515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 470 podiatrist providers in Texas.
Other podiatrist in Frisco
- Robert TaylorFrisco$99K
- Mojgan TavakoliFrisco$79K
- Brian CarpenterFort Worth$1.2M
- Gary LepowHouston$1M
- Wayne HurstCedar Park$625K
- Calvin RushingSunnyvale$452K
- Alan GarrettFort Worth$185K
- Gregory JarygaFt Worth$175K
- Brandon LampeMesquite$154K
- Andrew SchneiderHouston$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.